RXRX logo

RXRX Operating Expenses

Annual Operating Expenses:

$492.25M+$140.91M(+40.10%)
December 31, 2024

Summary

  • As of today, RXRX annual total operating expenses is $492.25 million, with the most recent change of +$140.91 million (+40.10%) on December 31, 2024.
  • During the last 3 years, RXRX annual operating expenses has risen by +$299.48 million (+155.35%).
  • RXRX annual operating expenses is now at all-time high.

Performance

RXRX Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRXRXincome statement metrics

Quarterly Operating Expenses:

$149.29M-$13.70M(-8.40%)
September 30, 2025

Summary

  • As of today, RXRX quarterly total operating expenses is $149.29 million, with the most recent change of -$13.70 million (-8.40%) on September 30, 2025.
  • Over the past year, RXRX quarterly operating expenses has increased by +$41.03 million (+37.90%).
  • RXRX quarterly operating expenses is now -13.50% below its all-time high of $172.58 million, reached on March 31, 2025.

Performance

RXRX Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRXRXincome statement metrics

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

RXRX Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+40.1%+37.9%
3Y3 Years+155.3%+147.8%
5Y5 Years+667.3%+564.3%

RXRX Operating Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+155.3%-13.5%+147.8%
5Y5-Yearat high+667.3%-13.5%+483.6%
All-TimeAll-Timeat high+667.3%-13.5%+719.5%

RXRX Operating Expenses History

DateAnnualQuarterly
Sep 2025
-
$149.29M(-8.4%)
Jun 2025
-
$162.99M(-5.6%)
Mar 2025
-
$172.58M(+2.3%)
Dec 2024
$492.25M(+40.1%)
$168.63M(+55.8%)
Sep 2024
-
$108.26M(+6.3%)
Jun 2024
-
$101.86M(+6.6%)
Mar 2024
-
$95.57M(-1.0%)
Dec 2023
$351.35M(+48.2%)
$96.54M(+0.8%)
Sep 2023
-
$95.81M(+17.2%)
Jun 2023
-
$81.75M(+17.8%)
Mar 2023
-
$69.40M(+9.0%)
Dec 2022
$237.13M
$63.67M(+5.7%)
DateAnnualQuarterly
Sep 2022
-
$60.25M(+1.2%)
Jun 2022
-
$59.56M(+11.5%)
Mar 2022
-
$53.44M(-17.7%)
Dec 2021
$192.78M(+119.0%)
$64.92M(+39.9%)
Sep 2021
-
$46.40M(+13.4%)
Jun 2021
-
$40.93M(+34.3%)
Mar 2021
-
$30.48M(+19.2%)
Dec 2020
$88.03M(+37.2%)
-
Dec 2020
-
$25.58M(+13.8%)
Sep 2020
-
$22.47M(+23.4%)
Jun 2020
-
$18.22M(-0.7%)
Mar 2020
-
$18.34M
Dec 2019
$64.15M
-

FAQ

  • What is Recursion Pharmaceuticals, Inc. annual total operating expenses?
  • What is the all-time high annual operating expenses for Recursion Pharmaceuticals, Inc.?
  • What is Recursion Pharmaceuticals, Inc. annual operating expenses year-on-year change?
  • What is Recursion Pharmaceuticals, Inc. quarterly total operating expenses?
  • What is the all-time high quarterly operating expenses for Recursion Pharmaceuticals, Inc.?
  • What is Recursion Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?

What is Recursion Pharmaceuticals, Inc. annual total operating expenses?

The current annual operating expenses of RXRX is $492.25M

What is the all-time high annual operating expenses for Recursion Pharmaceuticals, Inc.?

Recursion Pharmaceuticals, Inc. all-time high annual total operating expenses is $492.25M

What is Recursion Pharmaceuticals, Inc. annual operating expenses year-on-year change?

Over the past year, RXRX annual total operating expenses has changed by +$140.91M (+40.10%)

What is Recursion Pharmaceuticals, Inc. quarterly total operating expenses?

The current quarterly operating expenses of RXRX is $149.29M

What is the all-time high quarterly operating expenses for Recursion Pharmaceuticals, Inc.?

Recursion Pharmaceuticals, Inc. all-time high quarterly total operating expenses is $172.58M

What is Recursion Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?

Over the past year, RXRX quarterly total operating expenses has changed by +$41.03M (+37.90%)
On this page